Raia Drogasil
R$19.50Change from previous close: +4.00%Absolute change: +R$0.75
At a glance
- Revenue growth
- +13.84%
- 2025 vs 2024
- Net income growth
- +8.08%
- 2025 vs 2024
- Net margin
- 2.9%
- 2024: 3.1%
Financial data
Amounts in millions of BRL; per-share values in BRL; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total revenue | 44,250 | 38,872 | 33,974 | 29,067 | — |
| Cost of revenue | 31,286 | 27,315 | 23,766 | 20,258 | — |
| Gross profit | 12,965 | 11,557 | 10,207 | 8,809 | — |
| Selling, general and administrative | 10,290 | 9,198 | 8,193 | 7,056 | — |
| Operating income | 2,649 | 2,370 | 1,953 | 1,866 | — |
| EBIT | 2,514 | 2,232 | 1,954 | 1,752 | — |
| EBITDA | 3,563 | 3,144 | 2,752 | 2,453 | — |
| Interest expense | 1,066 | 813 | 738 | 559 | — |
| Pre-tax income | 1,448 | 1,419 | 1,217 | 1,193 | — |
| Income tax | 148 | 208 | 130 | 178 | — |
| Net income | 1,297 | 1,200 | 1,055 | 996 | — |
| Net income to common shareholders | 1,297 | 1,200 | 1,055 | 996 | — |
| Basic EPS | 0.79 | 0.71 | 0.61 | 0.57 | — |
| Diluted EPS | 0.78 | 0.71 | 0.61 | 0.57 | — |
| Average shares (basic) | 1,647 | 1,682 | 1,729 | 1,748 | — |
| Average shares (diluted) | 1,659 | 1,688 | 1,729 | 1,754 | — |